Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37003665)
Watch
English
Molecular targeted therapies in hepatocellular carcinoma
scientific article published on October 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Molecular targeted therapies in hepatocellular carcinoma
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
main subject
hepatocellular carcinoma
1 reference
based on heuristic
inferred from title
author
Josep M. Llovet
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
Jordi Bruix
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
Jordi Bruix
series ordinal
2
object named as
Jordi Bruix
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
retrieved
17 August 2017
language of work or name
English
0 references
publication date
1 October 2008
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
published in
Hepatology
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
volume
48
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
issue
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
page(s)
1312-1327
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
cites work
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Sorafenib in advanced hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
To kill a tumor cell: the potential of proapoptotic receptor agonists
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Drug development of MET inhibitors: targeting oncogene addiction and expedience
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Design and endpoints of clinical trials in hepatocellular carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Experimental models of hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Cetuximab for the treatment of colorectal cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Sorafenib in advanced clear-cell renal-cell carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Hepatocellular carcinoma pathogenesis: from genes to environment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
mTOR and cancer: insights into a complex relationship
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Strategies for optimizing combinations of molecularly targeted anticancer agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Management of hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Medicare and cost-effectiveness analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Erlotinib in previously treated non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Hepatocellular carcinoma: molecular pathways and new therapeutic targets.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Resection and liver transplantation for hepatocellular carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Hepatocellular carcinoma: epidemiology, risk factors, and screening
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Global cancer statistics, 2002
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
WNT and beta-catenin signalling: diseases and therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Cancer genes and the pathways they control
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Insulin-like growth factors and neoplasia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Focus on hepatocellular carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Rethinking clinical trials for cytostatic drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Protein kinases--the major drug targets of the twenty-first century?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
The protein tyrosine kinase family of the human genome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
The Hallmarks of Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
29 September 2017
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
27 June 2018
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Liver regeneration
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597642
retrieved
4 September 2018
Molecular pathogenesis of human hepatocellular carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18821591
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18821591
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Rising incidence of hepatocellular carcinoma in the United States
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18821591
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Hedgehog signaling in hepatocellular carcinoma: novel therapeutic strategy targeting hedgehog signaling in HCC
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18821591
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18821591
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Genomics and signaling pathways in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22506
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22506
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/HEP.22506
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
PMC publication ID
2597642
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
PubMed publication ID
18821591
1 reference
stated in
Europe PubMed Central
PMC publication ID
2597642
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821591%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
ResearchGate publication ID
23284818
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit